Scancell Holdings PLC | Mutual Funds
Mutual Funds that own Scancell Holdings PLC
Legal & General UK Alpha Trust
18,167,000
4.68%
0
1.35%
07/31/2018
City Financial Absolute Equity Fund
12,250,000
3.16%
-500,000
0.59%
09/29/2017
Helium Special Situations Fund Ltd.
7,095,580
1.83%
674,882
2.29%
12/31/2016
Investec Structured Products Calculus VCT Plc
2,531,012
0.65%
1,809,704
3.51%
02/28/2018
Hygea VCT Plc
0
0%
-13,023,613
0%
06/30/2017
| Address |
John Eccles House
Oxford Oxfordshire OX4 4GP
United Kingdom
|
|
Employees
|
- |
| Website |
http://scancell.co.uk |
| Updated |
07/08/2019 |
| Scancell Holdings Plc engages in the development of novel therapeutic vaccines for the treatment of cancer. It operates through ImmunoBody and Moditope technology platforms. The company was founded by Lindy Gillian Durrant in 1997 and is headquartered in Oxford, the United Kingdom. |
